Cimetidine augments Th1/Th2 dual polarized immune responses to recombinant HBV antigens

Vaccine

Volumn 29, Issue 29-30, 2011, Pages 4862-4868

  Zhang, Wenjuan ^a   Wang, Junpeng ^a,d   Su, Baowei ^a,e   Li, Ruiguo ^b   Ding, Zheng ^a   Kang, Youmin ^a   Wang, Bin ^a,c  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b Chinese National Center for Biotechnology Development   (China)

^c FUDAN UNIVERSITY   (China)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adjuvant; Cimetidine; HBV; Subunit; Vaccine

Indexed keywords

CIMETIDINE; HEPATITIS B ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; INTERLEUKIN 10; PROTEIN KINASE B; RECOMBINANT HEPATITIS B SURFACE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; UPREGULATION;

EID: 79960637990     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.091     Document Type: Article

References (15)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337(24):1733-45.
2. Lok ASF. Chronic hepatitis B. N Engl J Med 2002;346(22):1682-3.
3. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995;13(Suppl. 1):S47-9.
4. Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol 2004;82(5):488-96.
5. D'Souza R, Foster GR. Diagnosis and treatment of chronic hepatitis B. J R Soc Med 2004;97(7):318-21.
6. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007;204(3): 667-80.
7. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000;192(7): 921-30.
8. Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, et al. Gene inoculation generates immune responses against human immunodeficiency virus Type 1. PNAS 1993;90(9):4156-60.
9. Jin H, Li Y, Ma Z, Zhang F, Xie Q, Gu D, et al. Effect of chemical adjuvants on DNA vaccination. Vaccine 2004;22(21-22):2925-35.
10. Smit MJ, Leurs R, Alewijnse AE, Blauw J, Van Nieuw Amerongen GP, Van De Vrede Y, et al. Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc Natl Acad Sci USA 1996;93(13):6802-7.
11. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999;223(1): 77-92.
12. Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 2008;214(2):456-64.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65(1-2):55-63.
14. Du X, Zheng G, Jin H, Kang Y, Wang J, Xiao C, et al. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. J Gene Med 2007;9(2):136-46.
15. Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res 2003;63(11):2836-43.